The acylated/unacylated ghrelin ratio is similar in acromegaly patients during different treatment regimens.

Conclusions: Although plasma AG and UAG are suppressed during combination treatment of LA-SSA and PEGV, the AG/UAG ratio remained similar. This shows that somatostatin analogues decrease both AG and UAG, which suggest that they do not alter metabolism significantly in acromegaly patients. PMID: 28402548 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28402548?dopt=Abstract

Source: The Journal of Clinical Endocrinology and Metabolism - April 11, 2017 Category: Endocrinology Authors: Muhammad A, Delhanty PJ, Huisman M, Visser JA, van der Lelij AJ, Neggers SJ Tags: J Clin Endocrinol Metab Source Type: research